BACKGROUND: Borrelia burgdorferi, the causative agent of Lyme disease, has never been isolated from a patient thought to have acquired Lyme disease in any southeastern state. OBJECTIVE: To investigate 14 cases of an erythema migrans (EM)-like rash illness that occurred during 2 summers at an outdoor camp in central North Carolina in an effort to determine the etiologic, epidemiological, and clinical aspects of this illness. METHODS: Using active surveillance, we identified cases of clinically diagnosed EM in residents and staff of the camp. We collected clinical and demographic information; history of exposure to ticks; acute and convalescent serum antibodies to B. burgdorferi, Rickettsia rickettsii, and Ehrlichia chaffeensis; and cultures for spirochetes from biopsy specimens of skin lesions. Serum samples from a group of residents and staff who did not develop rashes were tested for the same antibodies. We speciated ticks removed from people and collected from vegetation. RESULTS: We identified 14 cases of EM-like rash illness during the 2 summers. Of the 14 case-patients, 10 had associated mild systemic symptoms and 1 had documented fever. All 14 case-patients had removed attached ticks, and 8 remembered having removed a tick from the site where the rash developed a median of 12 days earlier (range, 2-21 days). One tick removed from the site where a rash later developed was identified as Amblyomma americanum, the Lone Star tick; 97% of ticks collected from vegetation and 95% of ticks removed from people were A. americanum. No spirochetes were isolated from skin biopsy specimens. Paired serum samples from 13 case-patients did not show diagnostic antibody responses to B. burgdorferi or other tick-borne pathogens. CONCLUSIONS: This investigation suggests the existence of a new tick-associated rash illness. We suspect that the disease agent is carried by A. americanum ticks. In the southern United States, EM-like rash illness should no longer be considered definitive evidence of early Lyme disease.
BACKGROUND:Borrelia burgdorferi, the causative agent of Lyme disease, has never been isolated from a patient thought to have acquired Lyme disease in any southeastern state. OBJECTIVE: To investigate 14 cases of an erythema migrans (EM)-like rash illness that occurred during 2 summers at an outdoor camp in central North Carolina in an effort to determine the etiologic, epidemiological, and clinical aspects of this illness. METHODS: Using active surveillance, we identified cases of clinically diagnosed EM in residents and staff of the camp. We collected clinical and demographic information; history of exposure to ticks; acute and convalescent serum antibodies to B. burgdorferi, Rickettsia rickettsii, and Ehrlichia chaffeensis; and cultures for spirochetes from biopsy specimens of skin lesions. Serum samples from a group of residents and staff who did not develop rashes were tested for the same antibodies. We speciated ticks removed from people and collected from vegetation. RESULTS: We identified 14 cases of EM-like rash illness during the 2 summers. Of the 14 case-patients, 10 had associated mild systemic symptoms and 1 had documented fever. All 14 case-patients had removed attached ticks, and 8 remembered having removed a tick from the site where the rash developed a median of 12 days earlier (range, 2-21 days). One tick removed from the site where a rash later developed was identified as Amblyomma americanum, the Lone Star tick; 97% of ticks collected from vegetation and 95% of ticks removed from people were A. americanum. No spirochetes were isolated from skin biopsy specimens. Paired serum samples from 13 case-patients did not show diagnostic antibody responses to B. burgdorferi or other tick-borne pathogens. CONCLUSIONS: This investigation suggests the existence of a new tick-associated rash illness. We suspect that the disease agent is carried by A. americanum ticks. In the southern United States, EM-like rash illness should no longer be considered definitive evidence of early Lyme disease.
Authors: J H Oliver; K L Clark; F W Chandler; L Tao; A M James; C W Banks; L O Huey; A R Banks; D C Williams; L A Durden Journal: J Clin Microbiol Date: 2000-01 Impact factor: 5.948
Authors: Claudia R Molins; Laura V Ashton; Gary P Wormser; Barbara G Andre; Ann M Hess; Mark J Delorey; Mark A Pilgard; Barbara J Johnson; Kristofor Webb; M Nurul Islam; Adoracion Pegalajar-Jurado; Irida Molla; Mollie W Jewett; John T Belisle Journal: Sci Transl Med Date: 2017-08-16 Impact factor: 17.956
Authors: Gary P Wormser; Edwin Masters; Dionysios Liveris; John Nowakowski; Robert B Nadelman; Diane Holmgren; Susan Bittker; Denise Cooper; Guiqing Wang; Ira Schwartz Journal: Clin Infect Dis Date: 2005-01-10 Impact factor: 9.079
Authors: Andrea S Varela; M Page Luttrell; Elizabeth W Howerth; Victor A Moore; William R Davidson; David E Stallknecht; Susan E Little Journal: J Clin Microbiol Date: 2004-03 Impact factor: 5.948
Authors: Rendi Murphree Bacon; Mark A Pilgard; Barbara J B Johnson; Sandra J Raffel; Tom G Schwan Journal: J Clin Microbiol Date: 2004-05 Impact factor: 5.948
Authors: Jessica H Murdock; Michael J Yabsley; Susan E Little; Ramaswamy Chandrashekar; Thomas P O'Connor; Joe N Caudell; Jane E Huffman; Julia A Langenberg; Simon Hollamby Journal: Vector Borne Zoonotic Dis Date: 2009-12 Impact factor: 2.133
Authors: Victor A Moore; Andrea S Varela; Michael J Yabsley; William R Davidson; Susan E Little Journal: J Clin Microbiol Date: 2003-01 Impact factor: 5.948